Neurocrine Biosciences Inc. (NBIX)
NASDAQ · Healthcare
Neurocrine Biosciences Inc. Cash on Hand 2009–2025
Neurocrine Biosciences Inc. annual cash on hand history from 2010 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Neurocrine Biosciences Inc. cash on hand as of December 31, 2025: 713.0M, a 206.01% increase year-over-year.
- Neurocrine Biosciences Inc. cash on hand for 2025 were 713.0M, a 206.01% increase from 2024.
- Neurocrine Biosciences Inc. cash on hand for 2024 were 233.0M, a 7.21% decrease from 2023.
- Neurocrine Biosciences Inc. cash on hand for 2023 were 251.1M, a 4.49% decrease from 2022.
- Neurocrine Biosciences Inc. cash on hand for 2022 were 262.9M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Neurocrine Biosciences Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $713 |
| 2024 | $233 |
| 2023 | $251 |
| 2022 | $263 |
| 2021 | $341 |
| 2020 | $187 |
| 2019 | $112 |
| 2018 | $142 |
| 2017 | $255 |
| 2016 | $83 |
| 2015 | $74 |
| 2014 | $31 |
| 2013 | $45 |
| 2012 | $64 |
| 2011 | $50 |
Neurocrine Biosciences Inc. Cash on Hand — FAQ
Neurocrine Biosciences Inc. (NBIX) cash on hand over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see NBIX's cash on hand history?
The chart and table above show Neurocrine Biosciences Inc.'s cash on hand by year and by quarter, including the growth rate.